In an almost-macabre maneuver, the U.S. Centers for Disease Control and Prevention has pre-empted a vote by the their Advisory Committee on Immunization Practices (ACIP) by posting the jabs on a new childhood vaccination schedule two days before the vote. The ACIP is supposed to vote on whether to add the shots to the schedule sometime in the afternoon of Wednesday, October 19, 2022.
Whether the CDC is clairvoyant or the vote was already set and released to CDC officials is only a guess, but the bottom line is the new schedule has Moderna’s and Pfizer’s mRNA, gene therapy shots on the schedule for babies as young as 6 months old. They also have Jansen’s and Novavax’s COVID shots on the schedule for young adults age 18 and older.
Incidentally, footnotes at the bottom of the schedule acknowledge the risk of myocarditis with the shots. In a related post linked from the schedule and dated only with a “to-be-announced” note for October, the CDC elaborates on safety concerns for these shots.
SOURCES:
U.S. CDC. October 17, 2022
CDC October TBD 2022